Day: July 14, 2022

Uponor Corporation, Investor news, 14 July 2022 at 10:00 am EEST Uponor to publish Half-Year Financial Report on 27 July 2022 Uponor Corporation will publish its Half-Year Financial Report for the period January–June 2022 on Wednesday, 27 July 2022 around 8:00 am EEST. Webcast for analysts, investors, and media will be held on Wednesday, 27 July 2022, starting at 2:30 pm EEST. At the webcast, Uponor’s President and CEO Michael Rauterkus and CFO Markus Melkko will present the results. The webcast will be held in English and can be followed through the company website at uponorgroup.com, the Uponor IR app or through the webcast link: https://uponor.videosync.fi/2022-q2 The presentation material and the webcast recording will be available on the company website at https://www.uponorgroup.com/en-en/investors/reports-and-presentations/interim-reports/2022. You...

An Open Letter to European Policy Makers and the Media regarding the REPowerEU Plan The signatories to the letterERLANGEN, Germany, July 14, 2022 (GLOBE NEWSWIRE) — Fluence Energy, Inc. (“Fluence”) (Nasdaq: FLNC), a leading global provider of energy storage products and services and digital applications for renewables and storage, today, along with nine other signatories, released the following open letter to European policy makers and the media regarding the REPowerEU plan and the urgent need to rethink the structure of European energy markets. Specifically, the letter outlines why Europe needs a rapid rollout of technologies to increase grid flexibility, and strong targets and policy frameworks in place to encourage the near-term adoption of these technologies. The full letter follows: An Open Letter to European Policy Makers...

Ignitis Renewables Projektai, a subsidiary of Ignitis Renewables, which is owned by AB “Ignitis grupė” (hereinafter – the Group), on 13 July has signed a letter of intent with electricity transmission system operator Litgrid AB securing grid capacity in Jonava region, Lithuania for connection of 252 MW capacity solar park which is under development. Project’s final investment decision will be made at a later stage of the project’s development. Investments are estimated to reach up to EUR 200 million. It would be the largest greenfield investment project initiated by the Group thus far. Furthermore, in the future the Group sees an additional development potential in this location. The solar park is planned to be constructed and start generating electricity by 2025. The park should operate under market conditions. Project implementation...

Ignitis Renewables Projektai, a subsidiary of Ignitis Renewables, which is owned by AB “Ignitis grupė” (hereinafter – the Group), on 13 July has signed a letter of intent with electricity transmission system operator Litgrid AB securing grid capacity in Jonava region, Lithuania for connection of 252 MW capacity solar park which is under development. Project’s final investment decision will be made at a later stage of the project’s development. Investments are estimated to reach up to EUR 200 million. It would be the largest greenfield investment project initiated by the Group thus far. Furthermore, in the future the Group sees an additional development potential in this location. The solar park is planned to be constructed and start generating electricity by 2025. The park should operate under market conditions. Project implementation...

Intratumoral injection of allogeneic pro-inflammatory dendritic cells (“ilixadencel”) substantially and sustainably enhanced an otherwise ineffective systemic anti CTLA-4 treatment in an established in vivo cancer model Effects were shown to be T-cell-dependent and included a profound remodeling of the tumor microenvironment (TME), the formation of immune memory cells, and delivered results indicating the spread of the therapeutic effects into the periphery via the bloodstream and lymphoid organs Cured mice in the combination arm (7 out of 10) stayed tumor-free and survived for at least 70 days and sustained a subsequent tumor re-challengeMendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on improving survival outcomes for cancer patients with tumor recurrence through cell-based immunotherapies, today announced...

SAMPO PLC                 STOCK EXCHANGE RELEASE         14/07/2022 at 08:30 am Sampo plc’s share buybacks 13/07/2022 On 13/07/2022 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  9,040 41.19 AQEU  16,502 41.22 CEUX  8,795 41.19 TQEX  93,032 41.19 XHELTOTAL 127,369 41.19  *rounded to two decimals                 On 9 June 2022, Sampo announced a share buyback programme of up to a maximum of EUR 1 billion in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 10 June 2022, is based...